Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System, is pleased to announce the launch of i3 Prism, an early-stage technology commercialization fund focused on women and Black, Indigenous and people of color (BIPOC) health care innovators

The fund is launched by MSIP in partnership with the Diversity and Innovation Hub, led by Gary C. Butts, MD, Chief Diversity and Inclusion Officer for the Mount Sinai Health System; Mount Sinai BioDesign, directed by Joshua Bederson, MD, and Benjamin Rapoport, MD, PhD; the Graduate School of Biomedical Sciences, led by its Dean, Marta Filizola, PhD; the Windreich Department of Artificial Intelligence and Human Health, chaired by Thomas J. Fuchs,; the BioMedical Engineering and Imaging Institute at Icahn Mount Sinai, directed by Zahi Fayad, PhD; and the Mount Sinai ConduITS – Institutes for Translational Sciences, directed by Rosalind Wright, MD, MPH.

The fund aims to bring new health care solutions to patients and society, and advance technologies from women and BIPOC inventors to the next level from a commercial perspective. Awardees will receive up to $25,000-$33,000 in funding, based on their work’s milestone achievements.

Applicants must:

  • be individuals who identify as female and/or as BIPOC or teams with a female and/or BIPOC lead; preference will be given to diverse teams
  • be a Mount Sinai faculty or staff member or student; if the individual is within the research setting, they must be in the early stages of a scientific career (e.g., master’s, PhD, postdoctoral fellow, etc.)
  • have not previously received substantial funding for commercialization
  • submit the technology concept to MSIP via the Invention Disclosure Portal, including evidence of a development plan, prototype, and/or a minimum viable product or its equivalent

i3 Prism is a unique opportunity to provide support for women and BIPOC inventors, bring their innovations to life, and improve health and well-being for all people. Interested applicants should apply via the form available here. Applications will be accepted until Friday, April 15. Selected applicants will be notified by the beginning of summer. For more information, please reach out to Cynthia Cleto, MSc, Senior Director of Outreach, Entrepreneurship, and Special Programs at or Steffanie Haripersaud, Program Manager, at

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.